Extrapyramidal syndromes in nonhuman primates

Typical and atypical neuroleptics

Daniel Casey

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The traditional (typical) neuroleptic drugs produce acute extrapyramidal symptoms (EPS) in the majority of patients, whereas the atypical neuroleptics produce only minimal motor system side effects. Studies of acute dystonia in nonhuman primates with typical (haloperidol, fluphenazine), atypical (clozapine), and putative novel antipsychotic compounds with low EPS (remoxipride, melperone) were conducted across a wide dose range in double-blind, placebo-controlled trials. Haloperidol and fluphenazine caused dystonia, and clozapine did not. Remoxipride and melperone also produced dystonia, but remoxipride only did so at doses that were higher than needed for antipsychotic efficacy. Melperone produced dystonia in doses that are in the antipsychotic dose range. The clinical relevance of the findings is discussed.

Original languageEnglish (US)
Pages (from-to)47-50
Number of pages4
JournalPsychopharmacology Bulletin
Volume27
Issue number1
StatePublished - 1991
Externally publishedYes

Fingerprint

Remoxipride
Dystonia
Primates
Antipsychotic Agents
Fluphenazine
Clozapine
Haloperidol
Placebos
metylperon

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology

Cite this

Extrapyramidal syndromes in nonhuman primates : Typical and atypical neuroleptics. / Casey, Daniel.

In: Psychopharmacology Bulletin, Vol. 27, No. 1, 1991, p. 47-50.

Research output: Contribution to journalArticle

@article{20218119d7a94bf8a7a8ef97565af762,
title = "Extrapyramidal syndromes in nonhuman primates: Typical and atypical neuroleptics",
abstract = "The traditional (typical) neuroleptic drugs produce acute extrapyramidal symptoms (EPS) in the majority of patients, whereas the atypical neuroleptics produce only minimal motor system side effects. Studies of acute dystonia in nonhuman primates with typical (haloperidol, fluphenazine), atypical (clozapine), and putative novel antipsychotic compounds with low EPS (remoxipride, melperone) were conducted across a wide dose range in double-blind, placebo-controlled trials. Haloperidol and fluphenazine caused dystonia, and clozapine did not. Remoxipride and melperone also produced dystonia, but remoxipride only did so at doses that were higher than needed for antipsychotic efficacy. Melperone produced dystonia in doses that are in the antipsychotic dose range. The clinical relevance of the findings is discussed.",
author = "Daniel Casey",
year = "1991",
language = "English (US)",
volume = "27",
pages = "47--50",
journal = "Psychopharmacology Bulletin",
issn = "0048-5764",
publisher = "MedWorks Media LLC",
number = "1",

}

TY - JOUR

T1 - Extrapyramidal syndromes in nonhuman primates

T2 - Typical and atypical neuroleptics

AU - Casey, Daniel

PY - 1991

Y1 - 1991

N2 - The traditional (typical) neuroleptic drugs produce acute extrapyramidal symptoms (EPS) in the majority of patients, whereas the atypical neuroleptics produce only minimal motor system side effects. Studies of acute dystonia in nonhuman primates with typical (haloperidol, fluphenazine), atypical (clozapine), and putative novel antipsychotic compounds with low EPS (remoxipride, melperone) were conducted across a wide dose range in double-blind, placebo-controlled trials. Haloperidol and fluphenazine caused dystonia, and clozapine did not. Remoxipride and melperone also produced dystonia, but remoxipride only did so at doses that were higher than needed for antipsychotic efficacy. Melperone produced dystonia in doses that are in the antipsychotic dose range. The clinical relevance of the findings is discussed.

AB - The traditional (typical) neuroleptic drugs produce acute extrapyramidal symptoms (EPS) in the majority of patients, whereas the atypical neuroleptics produce only minimal motor system side effects. Studies of acute dystonia in nonhuman primates with typical (haloperidol, fluphenazine), atypical (clozapine), and putative novel antipsychotic compounds with low EPS (remoxipride, melperone) were conducted across a wide dose range in double-blind, placebo-controlled trials. Haloperidol and fluphenazine caused dystonia, and clozapine did not. Remoxipride and melperone also produced dystonia, but remoxipride only did so at doses that were higher than needed for antipsychotic efficacy. Melperone produced dystonia in doses that are in the antipsychotic dose range. The clinical relevance of the findings is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0025824232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025824232&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 47

EP - 50

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

SN - 0048-5764

IS - 1

ER -